Contact this trialFirst, we need to learn more about you.
Biguanide
Metformin for Oral Leukoplakia/Erythroplakia Prevention
Recruiting0 awardsPhase 2
Halifax, Nova Scotia
This trial tests if metformin can prevent oral cancer in patients with pre-cancerous mouth patches. Metformin is a diabetes drug that controls blood sugar and may stop these patches from becoming cancerous. Metformin, widely used as a diabetes medication, has recently been reported to reduce cancer risk and improve outcomes in certain cancers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service